Prenuvo Raises $70M Series A Led By Felicis to Reimagine Preventive Healthcare
Summary
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Prenuvo, a pioneer in advanced, radiation-free whole body imaging for early detection of cancer and other diseases, today announced that it has raised $70M in Series A equity and debt funding led by Felicis, with participation from existing investors including Tony Fadell, NYT bestseller author and founder of Nest; Dr. Timothy A. Springer, Lasker award recipient; Anne Wojcicki, CEO of 23&Me; Steel Perlot, with Eric Schmidt as chairman; entrepreneur Rande Gerber; and wellness investor, supermodel, and actress, Cindy Crawford. The funding will be used to invest in the companys artificial intelligence (AI) team, new radiology tools, custom advanced MRI builds, and national expansion.With Prenuvo, people and their doctors can reveal health problems early, if there are any, and gain peace of mind, if there are not. For many, health information comes too late, once a disease or condition has progressed, has symptoms, and is more difficult and expensive to treat, said Andrew Lacy, founder and CEO of Prenuvo. Our series A financing is validation of Prenuvos mission to catch conditions before they become crises and transform the healthcare approach as we know it to one that is rooted in proactive health.Research by Healthy People, a federal program administered by the Department of Health and Human Services (HHS), found that preventive health screenings and primary care consultations can significantly increase life expectancy, particularly among the 30-to 49-year age group, yet only 8% of U.S. adults receive appropriate preventive healthcare services each year. For more information visit us at prenuvo.com.Founded in 2006, Felicis is a venture capital firm investing in companies reinventing core markets, as well as those creating frontier technologies.